Loading...
•
Sep 30, 2023
ResMed Q1 2024 Earnings Report
ResMed's first quarter of fiscal year 2024 results were announced, featuring revenue growth and increased adoption of software solutions.
Key Takeaways
ResMed Inc. reported a 16% increase in revenue to $1.1 billion for the first quarter of fiscal year 2024. The company saw growth across global sleep and respiratory care markets and increased adoption of outside hospital software solutions. Diluted earnings per share were reported at $1.49, with non-GAAP diluted earnings per share at $1.64.
Revenue increased by 16% year-over-year, reaching $1.1 billion.
Operating profit grew by 5%, with non-GAAP operating profit up by 10%.
Diluted earnings per share were $1.49, and non-GAAP diluted earnings per share were $1.64.
The company expects to resume its share repurchase program during the upcoming quarter.
ResMed
ResMed
ResMed Revenue by Segment
ResMed Revenue by Geographic Location
Revenue by Segment
Total Devices Revenue
CapyFin.comTotal Masks and other Revenue
CapyFin.comRevenue by Geographic Location
U.S., Canada, and Latin America Revenue
CapyFin.comRevenue & Expenses
Visualization of income flow from segment revenue to net income